However, while LPA is known to play a substantial role in the pathogenesis of HCC (Balijepalli et al.; Erstad et al.; Magkrioti et al.; Memet et al.; Wu et al.), research investigating the application of ATX inhibitors as anticancer therapeutics for HCC remains markedly limited. Here, ENPP2 is linked to hepatocellular carcinoma.